In mouse models of AD, C5aR1 is most highly expressed in plaque-associated microglia18, and genetic ablation or inhibition of C5aR1 or C5a restores cognitive performance and reduces neuroinflammation19–22. Here, C5AR1 is linked to Alzheimer disease.